Skip to content

The effectiveness of Dexmedtomidine and propofol during ERCP

Comparison of the effectiveness of Dexmedtomidine and propofol during ERCP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190928044907N4
Enrollment
80
Registered
2021-08-27
Start date
2021-08-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation. Failed moderate sedation during procedure

Interventions

Intervention 1: Control group: : Fentanyl at a dose of one microgram per kilogram of body weight up to a maximum of 100 micrograms with first receiving 1 mg per kilogram of body weight of propofol as

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age18-65 years old Absence of cardiovascular disease ERCP candidate patients Do not take sedatives Absence of blood pressure Absence of respiratory disease Body Mass Index<30

Exclusion criteria

Exclusion criteria: History of drug abuse Medical allergy Kidney disease Liver disease Pregnancy

Design outcomes

Primary

MeasureTime frame
Heart Rate. Timepoint: Before starting the procedure, 5 minutes after starting, 15 minutes after starting the procedure and after finishing the work. Method of measurement: Number per minute.;O2 saturation. Timepoint: Before starting the procedure, 5 minutes after starting, 15 minutes after starting the procedure and after finishing the work. Method of measurement: Pulse oximeter.;Sedation. Timepoint: Before starting the procedure, 5 minutes after starting, 15 minutes after starting the procedure and after finishing the work. Method of measurement: Ramsay score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Hossein Hamidi

Babol University of Medical Sciences

s.hosseinhamidi@yahoo.com+98 11 3233 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026